
South Africa’s Saltzman family sees $28.6 million gain from Dis-Chem shares
This increase highlights the family's position as one of South Africa’s wealthiest.
This increase highlights the family's position as one of South Africa’s wealthiest.
This latest drop comes after a $26.33 million loss earlier in the year.
This comes after a period of growth in 2024, reflecting the group’s resilience last year.
This not only cements the Saltzman family’s status among South Africa’s wealthiest but also underscores Dis-Chem’s strong market performance.
This recent gain follows an earlier increase of $18.79 million between Sept. 13 and Oct. 26.
South Africa’s Saltzman family controls a 29.3 percent stake, equivalent to 302,066,319 ordinary shares in the Gauteng-based company.
This increase follows earlier gains recorded between April 24 and April 30, when the market value of the family’s stake surged by R433.55 million ($23.05 million)
The family’s recent financial gains come after experiencing losses between March 22 and April 18, during which the family’s joint stake in Dis-Chem fell by $44.1 million.
Despite the decline, the Saltzmans remain prominent investors on the Johannesburg Stock Exchange (JSE).
The $21.08-million increase in the market value of the Saltzman family’s stake in Dis-Chem solidifies their position as significant investors on the JSE.
Thanks to the recent upswing in Dis-Chem’s shares, the Saltzman family’s stake in Dis-Chem has surged by R776.36 million ($41.42 million) since Feb. 19.
The sell-off, a routine measure to trim his stakes in the leading group, follows Saltzman’s decision to step down as the CEO in June 2023.
By owning these critical assets outright, Dis-Chem aims to enhance its operational efficiency and ensure long-term strategic stability.
The market value of the Saltzman family’s joint stake in Dis-Chem Pharmacies has declined from $487.7 million on Jan. 1 to $465.61 million.
Lynette and Ivan Saltzman own a beneficial 35.12-percent stake in the Gauteng-based Dis-Chem Pharmacies.